Promore Pharma Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

Promore Pharma General Information

Description

PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.

Contact Information

Formerly Known As
Pergamum
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Fogdevreten 2
  • 171 65 Solna
  • Sweden
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Fogdevreten 2
  • 171 65 Solna
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Promore Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 29-Dec-2023 Completed Generating Revenue
6. Bankruptcy: Liquidation 29-Nov-2023 Cancelled Generating Revenue
5. IPO 06-Jul-2017 Completed Generating Revenue
4. Early Stage VC Completed Generating Revenue
3. Corporate 07-Jul-2016 Completed Generating Revenue
2. Angel (individual) 01-Jan-2016 $1.71M $1.72M Completed Startup
1. Accelerator/Incubator $5.74K $5.74K Completed Startup
To view Promore Pharma’s complete valuation and funding history, request access »

Promore Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Promore Pharma’s complete cap table history, request access »

Promore Pharma Patents

Promore Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180325807-A1 Method and apparatus for applying a pharmaceutical agent to reduce post-surgical adhesions Inactive 11-May-2017
CA-2825246-A1 Human lactoferrin based peptides having anti-inflammatory activity Inactive 26-Jan-2011
AU-2012210564-A1 Human lactoferrin based peptides having antiinflammatory activity Active 26-Jan-2011
AU-2012210564-B2 Human lactoferrin based peptides having antiinflammatory activity Inactive 26-Jan-2011
EP-2668204-A2 Human lactoferrin based peptides having antiinflammatory activity Active 26-Jan-2011 A61K38/10
To view Promore Pharma’s complete patent history, request access »

Promore Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Promore Pharma Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chalmers Ventures Venture Capital Minority
Granitor Venture Capital Minority
KDventures Venture Capital Minority
PharmaResearch (Pharmaceuticals) Corporation Minority
Rosetta Capital (UK) Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Promore Pharma Acquisitions (2)

Promore Pharma’s most recent deal was a Reverse Merger with PMD Device Solutions for . The deal was made on 29-Dec-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PMD Device Solutions 29-Dec-2023 Reverse Merger Monitoring Equipment
Pharmasurgics 01-Nov-2010 Merger/Acquisition Medical Supplies
To view Promore Pharma’s complete acquisitions history, request access »

Promore Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Pergasus Oxie, Sweden 2021

Promore Pharma FAQs

  • When was Promore Pharma founded?

    Promore Pharma was founded in 2002.

  • Where is Promore Pharma headquartered?

    Promore Pharma is headquartered in Solna, Sweden.

  • What is the size of Promore Pharma?

    Promore Pharma has 3 total employees.

  • What industry is Promore Pharma in?

    Promore Pharma’s primary industry is Drug Discovery.

  • Is Promore Pharma a private or public company?

    Promore Pharma is a Private company.

  • What is Promore Pharma’s current revenue?

    The current revenue for Promore Pharma is .

  • How much funding has Promore Pharma raised over time?

    Promore Pharma has raised $14M.

  • Who are Promore Pharma’s investors?

    Chalmers Ventures, Granitor, KDventures, PharmaResearch (Pharmaceuticals), and Rosetta Capital (UK) are 5 of 6 investors who have invested in Promore Pharma.

  • When was Promore Pharma acquired?

    Promore Pharma was acquired on 29-Dec-2023.

  • Who acquired Promore Pharma?

    Promore Pharma was acquired by PMD Device Solutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process